Coral Laboratories Q1 Results
- BSE: 524506
- NSE: -
- ISIN: INE683E01017
- Sector: Biotechnology & Drugs
BSE
436.35
-3.05 (-0.69%)
-3.05 (-0.69%)Volume3.79 K
Updated: Mon 16 Mar, 2026 | 14:18:31
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Coral Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 17.09 | 26.73 | -36.05% | 21.41 | -20.18% |
| Depreciation/ Amortization | 0.45 | 0.51 | -10.45% | 0.49 | -8.24% |
| Operating Income | 1.73 | 1.41 | 22.72% | 10.24 | -83.12% |
| Net Income | 2.56 | 2.83 | -9.29% | 8.80 | -70.87% |
| Other Operating Expenses Total | 4.48 | 7.05 | -36.42% | 3.90 | 14.95% |
| Net Income Before Taxes | 3.72 | 3.85 | -3.43% | 11.77 | -68.41% |
| Total Revenue | 18.82 | 28.13 | -33.10% | 31.66 | -40.54% |
| Selling/ General/ Admin Expenses Total | 3.42 | 3.83 | -10.72% | 3.59 | -4.70% |
| Diluted Normalized EPS | 7.18 | 9.49 | -24.38% | 24.64 | -70.86% |